Working memory (WM) deficits in neuropsychiatric disorders have often been attributed to altered dopaminergic signalling. Specifically, D2 receptor stimulation is thought to affect the ease with which items can be gated into and out of WM. In addition, this effect has been hypothesised to vary according to baseline WM ability, a putative index of dopamine synthesis levels. Moreover, whether D2 stimulation affects WM vicariously through modulating relatively WM-free cognitive control processes has not been explored.
Aims:
We examined the effect of administering a dopamine agonist on the ability to ignore or update information in WM.
Method:
A single dose of cabergoline (1 mg) was administered to healthy older adult humans in a within-subject, double-blind, placebo-controlled study. In addition, we obtained measures of baseline WM ability and relatively WM-free cognitive control (overcoming response conflict).
Results:
Consistent with predictions, baseline WM ability significantly modulated the effect that drug administration had on the proficiency of ignoring and updating. High-WM individuals were relatively better at ignoring compared to updating after drug administration. Whereas the opposite occurred in low-WM individuals. Although the ability to overcome response conflict was not affected by cabergoline, a negative relationship between the effect the drug had on response conflict performance and ignoring was observed. Thus, both response conflict and ignoring are coupled to dopaminergic stimulation levels.
Conclusions:
Cumulatively, these results provide evidence that dopamine affects subcomponents of cognitive control in a diverse, antagonistic fashion and that the direction of these effects is dependent upon baseline WM.
AartsEvan HolsteinMCoolsR (2011) Striatal dopamine and the interface between motivation and cognition. Front Psychol2: 163.
2.
Abi-DarghamAMawlawiOLombardoI, et al. (2002) Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci22: 3708–3719.
3.
ArnstenAFT (2006) Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J Clin Psychiatry67(Suppl. 8): 7–12.
4.
BäckmanLNybergLLindenbergerU, et al. (2006) The correlative triad among aging, dopamine, and cognition: Current status and future prospects. Neurosci Biobehav Rev30: 791–807.
5.
BloemendaalMvan SchouwenburgMRMiyakawaA, et al. (2015) Dopaminergic modulation of distracter-resistance and prefrontal delay period signal. Psychopharmacology232: 1061–1070.
6.
BroadwayJMFrankMJCavanaghJF (2018) Dopamine D2 agonist affects visuospatial working memory distractor interference depending on individual differences in baseline working memory span. Cogn Affect Behav Neurosci18: 509–520.
7.
BuckholtzJWTreadwayMTCowanRL, et al. (2010) Dopaminergic network differences in human impulsivity. Science329: 532–532.
8.
ChowdhuryRGuitart-MasipMLambertC, et al. (2013) Dopamine restores reward prediction errors in old age. Nat Neurosci16: 648–653.
9.
CohenJDBraverTSBrownJW (2002) Computational perspectives on dopamine function in prefrontal cortex. Curr Opin Neurobiol12: 223–229.
10.
CoolsRD’EspositoM (2011) Inverted-U–shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry69: e113–e125.
11.
CoolsRGibbsSEMiyakawaA, et al. (2008) Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci28: 1208–1212.
12.
DalleyJWEverittBJRobbinsTW (2011) Impulsivity, compulsivity, and top-down cognitive control. Neuron69: 680–694.
13.
DalleyJWFryerTDBrichardL, et al. (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science315: 1267–1270.
14.
del CampoNFryerTDHongYT, et al. (2013) A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: Implications for ADHD and its treatment. Brain136: 3252–3270.
15.
DoddsCMClarkLDoveA, et al. (2009) The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology207: 35–45.
16.
DurstewitzDSeamansJK (2008) The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia. Biol Psychiatry64: 739–749.
17.
EagleDMBariARobbinsTW (2008) The neuropsychopharmacology of action inhibition: Cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology199: 439–456.
18.
EagleDMWongJCKAllanME, et al. (2011) Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci31: 7349–7356.
19.
FallonSJMattiesingRMMuhammedK, et al. (2017a) Fractionating the neurocognitive mechanisms underlying working memory: Independent effects of dopamine and Parkinson’s disease. Cereb Cortex27: 5727–5738.
20.
FallonSJMuhammedKDrewDS, et al. (2019) Dopamine guides competition for cognitive control: Common effects of haloperidol on working memory and response conflict. Cortex113: 156–168.
21.
FallonSJvan der SchaafMEter HuurneN, et al. (2017b) The neurocognitive cost of enhancing cognition with methylphenidate: Improved distractor resistance but impaired updating. J Cogn Neurosci29: 652–663.
22.
FallonSJZokaeiNNorburyA, et al. (2017c) Dopamine alters the fidelity of working memory representations according to attentional demands. J Cogn Neurosci29: 728–738.
23.
FrankMJO’ReillyRC (2006) A mechanistic account of striatal dopamine function in human cognition: Psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci120: 497–517.
24.
Guitart-MasipMSalamiAGarrettD, et al. (2016) BOLD variability is related to dopaminergic neurotransmission and cognitive aging. Cereb Cortex26: 2074–2083.
25.
JahanshahiMObesoIRothwellJC, et al. (2015) A fronto–striato–subthalamic–pallidal network for goal-directed and habitual inhibition. Nat Rev Neurosci16: 719–732.
26.
JASP Team (2018) JASP (Version 0.9)[Computer software]. Available at: https://jasp-stats.org/.
27.
KaasinenVRinneJO (2002) Functional imaging studies of dopamine system and cognition in normal aging and Parkinson’s disease. Neurosci Biobehav Rev26: 785–793.
28.
KarrerTMJosefAKMataR, et al. (2017) Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: A meta-analysis. Neurobiol Aging57: 36–46.
29.
KimbergDYD’EspositoM (2003) Cognitive effects of the dopamine receptor agonist pergolide. Neuropsychologia41: 1020–1027.
30.
KimbergDYD’EspositoMFarahMJ (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport8: 3581–3585.
31.
LiSCPapenbergGNagelIE, et al. (2013) Aging magnifies the effects of dopamine transporter and D2 receptor genes on backward serial memory. Neurobiol Aging34: 358.e1–358.e10.
32.
LogemannHABöckerKBDeschampsPK, et al. (2017) Haloperidol 2 mg impairs inhibition but not visuospatial attention. Psychopharmacology234: 235–244.
33.
LucianaMDepueRAArbisiP, et al. (1992) Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci4: 58–68.
34.
ManoharSGZokaeiNFallonSJ, et al. (2019) Neural mechanisms of attending to items in working memory. Neurosci Biobehav Rev101: 1–12.
35.
McNabFKlingbergT (2008) Prefrontal cortex and basal ganglia control access to working memory. Nat Neurosci11: 103–107.
36.
McNabFZeidmanPRutledgeRB, et al. (2015) Age-related changes in working memory and the ability to ignore distraction. Proc Natl Acad Sci U S A112: 6515–6518.
37.
MehtaMAManesFFMagnolfiG, et al. (2004) Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology176: 331–342.
38.
MellerEBohmakerKNambaY, et al. (1987) Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol Pharmacol31: 592–598.
39.
MurtyVPSambataroFRadulescuE, et al. (2011) Selective updating of working memory content modulates meso-cortico-striatal activity. Neuroimage57: 1264–1272.
40.
NieoullonA (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol67: 53–83.
41.
O’ReillyRCFrankMJ (2006) Making working memory work: A computational model of learning in the prefrontal cortex and basal ganglia. Neural Comput18: 283–328.
42.
OttTNiederA (2017) Dopamine D2 receptors enhance population dynamics in primate prefrontal working memory circuits. Cereb Cortex27: 4423–4435.
43.
RamdaniCCarbonnellLVidalF, et al. (2015) Dopamine precursors depletion impairs impulse control in healthy volunteers. Psychopharmacology232: 477–487.
44.
RieckmannAKarlssonSFischerH, et al. (2011) Caudate dopamine D1 receptor density is associated with individual differences in frontoparietal connectivity during working memory. J Neurosci31: 14284–14290.
45.
SawaguchiTGoldman-RakicPS (1991) D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science251: 947–950.
46.
TabiYAHusainMManoharSG (2019) Recall cues interfere with retrieval from visuospatial working memory. Br J Psychol110: 288–305.
47.
ter HuurneNFallonSJvan SchouwenburgM, et al. (2015) Methylphenidate alters selective attention by amplifying salience. Psychopharmacology232: 4317–4323.
48.
van der SchaafMEFallonSJter HuurneN, et al. (2013) Working memory capacity predicts effects of methylphenidate on reversal learning. Neuropsychopharmacology38: 2011–2018.
49.
van der SchaafMEvan SchouwenburgMRGeurtsDE, et al. (2014) Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning. Cereb Cortex24: 633–642.
50.
van HolsteinMAartsEvan der SchaafME, et al. (2011) Human cognitive flexibility depends on dopamine D2 receptor signaling. Psychopharmacology218: 567–578.
51.
van WouweNCKanoffKEClaassenDO, et al. (2016) Dissociable effects of dopamine on the initial capture and the reactive inhibition of impulsive actions in Parkinson’s disease. J Cogn Neurosci Epub ahead of print 2 February 2016. DOI: 10.1162/jocn_a_00930.
52.
VolkowNDWangGJTomasiD, et al. (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci32: 841–849.
53.
ZhangWBymasterFP (1999) The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology141: 267–278.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
